Nomura Research Institute, Ltd.
NURAF
$37.72
-$0.88-2.28%
OTC PK
| 03/31/2024 | 12/31/2023 | ||||
|---|---|---|---|---|---|
| Revenue | -1.31% | -0.76% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -1.31% | -0.76% | |||
| Cost of Revenue | -1.25% | -1.16% | |||
| Gross Profit | -1.43% | -0.02% | |||
| SG&A Expenses | 1.67% | 4.81% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 142.50% | -439.94% | |||
| Total Operating Expenses | 0.91% | -0.69% | |||
| Operating Income | -12.12% | -1.06% | |||
| Income Before Tax | -12.42% | 0.33% | |||
| Income Tax Expenses | 12.20% | -22.79% | |||
| Earnings from Continuing Operations | -20.97% | 11.96% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -37.13% | 12.69% | |||
| Net Income | -21.28% | 12.13% | |||
| EBIT | -12.12% | -1.06% | |||
| EBITDA | -9.38% | -0.74% | |||
| EPS Basic | -21.24% | 13.66% | |||
| Normalized Basic EPS | -14.89% | 1.80% | |||
| EPS Diluted | -21.21% | 13.71% | |||
| Normalized Diluted EPS | -14.90% | 1.85% | |||
| Average Basic Shares Outstanding | -0.06% | -1.36% | |||
| Average Diluted Shares Outstanding | -0.07% | -1.37% | |||
| Dividend Per Share | -- | -100.00% | |||
| Payout Ratio | -1.00% | -- | |||